GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

Submitted by admin on November 30, 2023 - 11:12pm
Source: 
Reuters
News Tags: 
GSK
RSV
vaccines
Emma Walmsley
Pharma CEOs
Headline: 
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
snippet: 
  • GSK shares have lagged rivals in recent years
  • Zantac litigation 'clear overhang' on stock-CEO
  • Walmsley defends GSK's work on drug pipeline
  • RSV vaccine data for U.S. for 50-59 year olds by year-end-CEO

Do Not Allow Advertisers to Use My Personal information